Review Article
    Pharmacognosy Reviews
    Vol. 19
    Issue 38
    2025
    pp. 138-143
    Open Access

    Nothapodytes nimmoniana: Untapped Potential

    Sharada Laxman Deore1,Ram Chhatrapati Vighne1,Bhushan Arun Baviskar1
    1Deparment of Pharmacognosy, Government College of Pharmacy, Amravati, Maharashtra, INDIA.
    Correspondence:

    *Sharada Laxman Deore

    Deparment of Pharmacognosy, Government College of Pharmacy, Amravati, Maharashtra, INDIA.

    sharudeore_2@yahoo.com

    Copyright:

    2025 Author(s)

    Check for updates
    Published:17/10/2025
    Received: 11/04/2025
    Accepted: 25/08/2025

    Abstract

    The tree species Nothapodytes nimmoniana or Nothapodytes foetida or Mappia foetida of family Icacinaceae commonly known as Ghanera or narakya is of research interest among plant scientist as it contains third most demanding anticancer compound camptothecin and 9-Methoxy camptothecin mainly used for treatment of cervical, breast cancer and few lymphomas. Due to extensive overharvesting to meet market demand of camptothecin, it is now red-listed as per IUCN. More than a 20% decline is reported in N. nimmoniana population in the last decade alone. Conservation efforts are underway, including metabolic engineering of plant cells to boost camptothecin production, aiming to reduce pressure on wild populations. This article provides an overview of pharmacognosy, phytochemistry, pharmacology and biotechnology aspects of Nothapodytes nimmonianaJ. Graham.

    Share on Mobile

    Scan to access on mobile

    Keywords

    Camptothecin
    Plant tissue culture
    Anticancer
    Conservation
    No content available

    Related Articles